17 results

• Metformin Contaminated With Cancer-Causing Chemicals NDMA in Other Countries, Sparking FDA Investigation

  December 6, 2019

  Irvin Jackson

  The FDA is investigating whether some metformin, a diabetes medication, may be contaminated with cancer-causing levels of NDMA.

• Problems At Valsartan Manufacturing Plant Found in New FDA Inspection

  November 7, 2019

  Irvin Jackson

  Aurobindo reports that the FDA has found more problems at its India production facilities during inspections last month in the wake of valsartan recalls.

• Experts Predict More Drug Recalls Coming Based On NDMA Contamination Problems

  November 6, 2019

  Irvin Jackson

  Consumers should expect additional drug recalls due to NDMA contamination, according to a recent report.

• FDA Taking Too Long To Assess Cancer Problems with Valsartan, Other Blood Pressure Drugs: Report

  October 11, 2019

  Austin Kirk

  A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.

• Valsartan Pancreatic Cancer Diagnosis Resulted in Wrongful Death, Lawsuit Alleges

  August 7, 2019

  Irvin Jackson

  A wrongful death lawsuit claims recalled generic valsartan tablets containing manufacturing impurities caused a man's lethal case of pancreatic cancer.

• Only One-Fifth Of Cancer Drugs Approved Through Accelerated FDA Program Actually Work: Study

  May 31, 2019

  Martha Garcia

  Most cancer drugs fast-tracked through a special FDA program do not appear to actually help cancer patients live longer, according to the findings of a new study.

• FDA Seeks To Reassure Public On Generic Drug Oversight Following Valsartan Recalls

  May 22, 2019

  Irvin Jackson

  An FDA blog post says the agency is adequately protecting the country's generic supply chain following months of recalls and claims by a former inspector that the agency is dropping the ball.